Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
Clinical trial NCT07390123 · RECRUITING
Trial details
- NCT number
- NCT07390123
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-07
- Primary completion
- 2027-12-01
- Enrollment
- 370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.